Dow Jones
33.717,09 -260,99 (-0,77%) Nasdaq
11.393,81 -227,90 (-1,96%) Nikkei 225
27.394,01 -39,39 (-0,14%) EUR/USD
1,0847 -0,0009 (-0,09%) BTC-EUR
21.072,70 -962,47 (-4,37%) CMC Crypto 200
518,39 -19,48 (-3,62%)
Alphabet Inc. (GOOG)
Dopo ore:
| Chiusura precedente | 100,71 |
| Aperto | 98,75 |
| Denaro | 98,13 x 1000 |
| Lettera | 98,21 x 1200 |
| Min-Max giorno | 97,52 - 99,41 |
| Intervallo di 52 settimane | 83,45 - 152,10 |
| Volume | |
| Media Volume | 26.356.756 |
| Capitalizzazione | 1,259T |
| Beta (5 anni mensile) | 1,07 |
| Rapporto PE (ttm) | 18,69 |
| EPS (ttm) | 5,24 |
| Prossima data utili | 24 apr 2023 - 28 apr 2023 |
| Rendimento e dividendo (forward) | N/D (N/D) |
| Data ex dividendo | N/D |
| Stima target 1A | 124,70 |
- CoinDesk
Tech’s Money Woes: Beginning of the End for Web2?
Gloomy forecasts, mass layoffs and antitrust lawsuits have bruised "Big Tech" over the past year. But that doesn't automatically portend the end of Web2. For Web3 to emerge, we have to address key questions about AI and decentralization.
- GlobeNewswire
Purpose Investments Debuts Yield Shares, the World’s First Yield-Focused Single-Stock ETFs
Yield Shares seek to provide investors with enhanced* monthly distributions from individual stocks of world-class companiesTORONTO, Dec. 20, 2022 (GLOBE NEWSWIRE) -- Purpose Investments Inc. (“Purpose Investments”), a modern investment firm known for its globally innovative, client-centric products, is excited to announce the launch of Yield Shares by Purpose (“Yield Shares”), as described in the table below, the world’s first yield-focused single-stock ETFs, which will begin trading today on th
- GlobeNewswire
RadNet’s Aidence Artificial Intelligence (AI) Subsidiary and Google Health Enter into Collaboration to Help Improve Lung Cancer Screening with AI Solutions
LOS ANGELES, Nov. 28, 2022 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services today reported that its lung artificial intelligence subsidiary, Aidence, and Google Health, a division of Alphabet, Inc. (NASDAQ: GOOG), announce an agreement to license Google Health’s AI research model for lung nodule malignancy prediction on CT imaging. Aidence will develop, validate and bring this model to
